How Can We Help?
Skip to content
Lab technician with dropper into lab test tubes

Enzyme Induction Studies to Evaluate Drug-Drug Interaction Potential

Enzyme Induction studies assess the potential for a drug candidate to induce (up-regulate) the expression of drug-metabolizing enzymes, resulting in increased clearance of the drug or another metabolized compound.

Induction studies fall into two categories: in vitro and ex vivo. In vitro studies evaluate the test article for its perpetrator potential using primary cultures of hepatocytes from human and/or other species, while ex vivo experiments in monkey, dog, rat, and mouse liver microsomes can identify the species with the closest induction profile to humans and help explain unexpected results in animal pharmacokinetic/pharmacodynamic (PK/PD), absorption, metabolism, distribution, and excretion (ADME), and toxicology studies.

Enzyme induction data is key to the evaluation of drug-drug interaction (DDI) potential of your compound.

To address direction from the Food and Drug Administration (FDA) to “determine if the investigational drug is an inducer of drug-metabolizing enzymes” (In Vitro Drug Interactions Studies— Cytochrome P450 Enzyme- and Transporter-Mediated Drug Interactions: Final Guidance for Industry, FDA 2020), we offer in vitro and ex vivo enzyme induction studies designed to meet current FDA, European Medicines Agency (EMA), and Pharmaceuticals and Medical Devices Agency (PMDA) expectations for new drug applications.

CYP Induction screening can offer quick results for how a drug candidate could cause a metabolism-mediated drug-drug interaction (DDI

Cytochrome P450 (CYP) Induction assays allow evaluation of up-regulation of CYP enzymes by a drug candidate and may help better predict drug-drug interaction (DDI) potential and inform the design of any necessary clinical studies.

UDP glucuronyltransferase (UGT) Induction assays provide information to evaluate the risk of drug-drug interactions (DDI) with other drugs that may be cleared by UGT enzymes.

Ex Vivo Induction experiments involving treated monkey, dog, rat, and mouse liver microsomes can identify the species with the closest induction profile to humans and help explain unexpected results in other preclinical or clinical studies.

Frequently Asked Questions regarding enzyme induction study design and results

You asked, we answered.

Read our blog post or watch our webinar in which VP of Scientific Operations, Dr. Joanna Barbara, answers frequently asked questions such as “How are test article concentrations selected?” and “Why do I need to do spent media analysis?” Our experts walk you through each part of the study, reasoning for controls and study design elements, regulatory expectations, information gleaned from results, and more

Automation and Analysis

  • Validated qRT-PCR methods
  • Tecan liquid handling systems or manual incubations available
  • Validated LC-MS/MS methods for activity endpoints
  • Deuterated internal standards (all CYPs and most UGTs) for activity endpoints
  • Comprehensive, publication-quality reports

Related Services: CYP Induction Screening

Discovery Plus™ Screening Suite presents medium-throughput alternatives to definitive metabolism & DDI studies through non-GLP, abbreviated versions of our definitive assays. This option is best used for comparison of multiple compounds (during the Lead Optimization stage) or to yield preliminary data for definitive in vitro studies.

Take an induction crash course

Find out more about how calculations are formulated, spent media analysis, best test systems, and TA concentrations in our webinar, “In Vitro Induction Studies: Elements of Design and Important Considerations in Data Analysis”

CTA - Products 7 - Subcellular fraction test systems preparation

Downloadable Flyer

Get up to speed on how you can make sure your in vitro DDI study data will meet expectations for your IND application

Products 8 enzymes